BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38598696)

  • 1. Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
    Kolte B; Nübel U
    J Antimicrob Chemother; 2024 Jun; 79(6):1320-1328. PubMed ID: 38598696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water.
    Cizek A; Masarikova M; Mares J; Brajerova M; Krutova M
    Microbiol Spectr; 2022 Aug; 10(4):e0080622. PubMed ID: 35950844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile.
    Pu M; Cho JM; Cunningham SA; Behera GK; Becker S; Amjad T; Greenwood-Quaintance KE; Mendes-Soares H; Jones-Hall Y; Jeraldo PR; Chen J; Dunny G; Patel R; Kashyap PC
    Gastroenterology; 2021 Feb; 160(3):941-945.e8. PubMed ID: 33197449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of Circulating
    Martínez-Meléndez A; Tijerina-Rodríguez L; Collins N; Baines SD; Morfin-Otero R; Camacho-Ortíz A; Villarreal-Treviño L; Garza-González E
    Microb Drug Resist; 2021 Dec; 27(12):1672-1676. PubMed ID: 34037477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-Based Identification of Metronidazole-Resistant Clostridioides difficile Isolates.
    Smits WK; Harmanus C; Sanders IMJG; Bry L; Blackwell GA; Ducarmon QR; de Oliveira Ferreira E; Kuijper EJ
    Emerg Infect Dis; 2022 Nov; 28(11):2308-2311. PubMed ID: 36286226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
    Jon J V; Mark H W; Jane F
    Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.
    Costa DVS; Pham NVS; Hays RA; Bolick DT; Goldbeck SM; Poulter MD; Hoang SC; Shin JH; Wu M; Warren CA
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0048922. PubMed ID: 35861541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dogs as carriers of virulent and resistant genotypes of Clostridioides difficile.
    Finsterwalder SK; Loncaric I; Cabal A; Szostak MP; Barf LM; Marz M; Allerberger F; Burgener IA; Tichy A; Feßler AT; Schwarz S; Monecke S; Ehricht R; Ruppitsch W; Spergser J; Künzel F
    Zoonoses Public Health; 2022 Sep; 69(6):673-681. PubMed ID: 35546073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
    Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid-mediated metronidazole resistance in Clostridioides difficile.
    Boekhoud IM; Hornung BVH; Sevilla E; Harmanus C; Bos-Sanders IMJG; Terveer EM; Bolea R; Corver J; Kuijper EJ; Smits WK
    Nat Commun; 2020 Jan; 11(1):598. PubMed ID: 32001686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
    Gargis AS; Karlsson M; Paulick AL; Anderson KF; Adamczyk M; Vlachos N; Kent AG; McAllister G; McKay SL; Halpin AL; Albrecht V; Campbell D; Korhonen LC; Elkins CA; Rasheed JK; Guh AY; McDonald LC; Lutgring JD;
    Clin Infect Dis; 2023 Mar; 76(5):890-896. PubMed ID: 36208202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The
    Wickramage I; Peng Z; Chakraborty S; Harmanus C; Kuijper EJ; Alrabaa S; Smits WK; Sun X
    Microbiol Spectr; 2023 Jun; 11(3):e0377722. PubMed ID: 37125917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on mechanisms of antibiotic resistance in Clostridioides difficile.
    Teng X; Hai-Hui H
    Yi Chuan; 2023 Nov; 45(11):1028-1038. PubMed ID: 38764268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?
    Krutova M; Wilcox M; Kuijper E
    Int J Infect Dis; 2022 Nov; 124():118-123. PubMed ID: 36155825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxin genotypes, antibiotic resistance and their correlations in Clostridioides difficile isolated from hospitals in Xi'an, China.
    Zhang S; Ma C; Zhang H; Zhao C; Guo R; Liu J; Wang J; Yuan J; Jia K; Wu A; Chen Y; Lei J
    BMC Microbiol; 2024 May; 24(1):177. PubMed ID: 38783194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran.
    Kouhsari E; Douraghi M; Krutova M; Fakhre Yaseri H; Talebi M; Baseri Z; Moqarabzadeh V; Sholeh M; Amirmozafari N
    J Glob Antimicrob Resist; 2019 Sep; 18():28-33. PubMed ID: 30703583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in Clostridioides difficile.
    O'Grady K; Knight DR; Riley TV
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2459-2478. PubMed ID: 34427801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
    Cheng JW; Liu C; Kudinha T; Xiao M; Fan X; Yang CX; Wei M; Liang GW; Shao DH; Xiong ZJ; Hou X; Yu SY; Wang Y; Yang QW; Su JR; Xu YC
    Int J Antimicrob Agents; 2020 Jul; 56(1):105981. PubMed ID: 32330584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.